Research Landscape

Improving care through evidence and innovation.

What we know:

• BEST-2: Azithromycin vs. Co-amoxiclav
• Macrolides: Reduce exacerbation frequency
• ERS Guidelines: Standard for global care

Key Research Priorities:

• P. aeruginosa management
• Optimal mucolytic therapy
• Earlier diagnosis and standardised imaging
• Reducing regional disparities